Latest TANG CAPITAL MANAGEMENT LLC Stock Portfolio
TANG CAPITAL MANAGEMENT LLC Performance:
2025 Q2: 1.23%YTD: -4.13%2024: -1.07%
Performance for 2025 Q2 is 1.23%, and YTD is -4.13%, and 2024 is -1.07%.
About TANG CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, TANG CAPITAL MANAGEMENT LLC reported an equity portfolio of $2 Billions as of 30 Jun, 2025.
The top stock holdings of TANG CAPITAL MANAGEMENT LLC are , TARS, AUPH. The fund has invested 5.6% of it's portfolio in GALAPAGOS NV and 5% of portfolio in TARSUS PHARMACEUTICALS INC.
The fund managers got completely rid off INTRA-CELLULAR THERAPIES INC (ITCI), ACELYRIN INC and BEIGENE LTD (BGNE) stocks. They significantly reduced their stock positions in DYNAVAX TECHNOLOGIES CORP (DVAX), ONKURE THERAPEUTICS INC and JPMORGAN CHASE & CO. (JPM). TANG CAPITAL MANAGEMENT LLC opened new stock positions in METTLER-TOLEDO INTERNATIONAL (MTD), UROGEN PHARMA LTD (URGN) and TRAVERE THERAPEUTICS INC (TVTX). The fund showed a lot of confidence in some stocks as they added substantially to BOEING CO (BA), SUTRO BIOPHARMA INC (STRO) and VERA THERAPEUTICS INC CL A (VERA).
The top stock holdings of TANG CAPITAL MANAGEMENT LLC are , TARS, AUPH. The fund has invested 5.6% of it's portfolio in GALAPAGOS NV and 5% of portfolio in TARSUS PHARMACEUTICALS INC.
The fund managers got completely rid off INTRA-CELLULAR THERAPIES INC (ITCI), ACELYRIN INC and BEIGENE LTD (BGNE) stocks. They significantly reduced their stock positions in DYNAVAX TECHNOLOGIES CORP (DVAX), ONKURE THERAPEUTICS INC and JPMORGAN CHASE & CO. (JPM). TANG CAPITAL MANAGEMENT LLC opened new stock positions in METTLER-TOLEDO INTERNATIONAL (MTD), UROGEN PHARMA LTD (URGN) and TRAVERE THERAPEUTICS INC (TVTX). The fund showed a lot of confidence in some stocks as they added substantially to BOEING CO (BA), SUTRO BIOPHARMA INC (STRO) and VERA THERAPEUTICS INC CL A (VERA).
TANG CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500
Our best estimate is that TANG CAPITAL MANAGEMENT LLC made a return of 1.23% in the last quarter. In trailing 12 months, it's portfolio return was -3.13%.
New Buys
| Ticker | $ Bought |
|---|---|
| mettler-toledo international | 22,907,000 |
| urogen pharma ltd | 13,700,000 |
| travere therapeutics inc | 10,360,000 |
| genedx holdings corp | 9,231,000 |
| eli lilly & co | 7,795,300 |
| sarepta therapeutics inc | 7,187,130 |
| alumis inc | 5,990,390 |
| summit therapeutics inc | 5,320,000 |
New stocks bought by TANG CAPITAL MANAGEMENT LLC
Additions
| Ticker | % Inc. |
|---|---|
| boeing co | 1,641 |
| sutro biopharma inc | 1,180 |
| vera therapeutics inc cl a | 800 |
| merus n v | 500 |
| beam therapeutics inc | 310 |
| idexx labs inc | 220 |
| pyxis oncology inc | 127 |
| insmed inc | 100 |
Additions to existing portfolio by TANG CAPITAL MANAGEMENT LLC
Reductions
| Ticker | % Reduced |
|---|---|
| dynavax technologies corp | -66.1 |
| onkure therapeutics inc | -57.69 |
| astrazeneca plc | -40.00 |
| jpmorgan chase & co. | -28.71 |
| walmart inc | -27.56 |
| microsoft corp | -26.51 |
| berkshire hathaway inc del | -26.15 |
| sanofi | -25.93 |
TANG CAPITAL MANAGEMENT LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| acelyrin inc | -24,250,700 |
| allakos inc | -1,978,680 |
| elevation oncology inc | -1,233,320 |
| kronos bio inc | -1,109,970 |
| phathom pharmaceuticals inc | -7,524,000 |
| lexicon pharmaceuticals inc | -530,043 |
| reviva pharmaceutcls hldgs i | -486,752 |
| vir biotechnology inc | -3,240,000 |
TANG CAPITAL MANAGEMENT LLC got rid off the above stocks
Sector Distribution
TANG CAPITAL MANAGEMENT LLC has about 73.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 73.2 |
| Others | 21 |
| Technology | 1.3 |
| Industrials | 1.3 |
| Communication Services | 1.3 |
Market Cap. Distribution
TANG CAPITAL MANAGEMENT LLC has about 10.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 42.5 |
| UNALLOCATED | 24.3 |
| MID-CAP | 14.1 |
| MICRO-CAP | 7.9 |
| LARGE-CAP | 7.5 |
| MEGA-CAP | 3.4 |
Stocks belong to which Index?
About 62.7% of the stocks held by TANG CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54.1 |
| Others | 37.3 |
| S&P 500 | 8.6 |
TANG CAPITAL MANAGEMENT LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLC has 200 stocks in it's portfolio. About 35% of the portfolio is in top 10 stocks. TARS proved to be the most loss making stock for the portfolio. CTMX was the most profitable stock for TANG CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| galapagos nv | 5.64 | 3,990,110 | 111,683,000 | added | 0.71 | |||
| TARS | tarsus pharmaceuticals inc | 5.03 | 2,454,800 | 99,443,800 | unchanged | 0.00 | ||
| AUPH | aurinia pharmaceuticals inc | 4.29 | 10,029,500 | 84,949,900 | unchanged | 0.00 | ||
| IMCR | immunocore hldgs plc | 3.34 | 2,105,610 | 66,074,000 | added | 9.91 | ||
| kiniksa pharmaceuticals intl | 3.26 | 2,328,610 | 64,432,600 | added | 9.91 | |||
| MIRM | mirum pharmaceuticals inc | 3.18 | 1,236,030 | 62,901,400 | reduced | -0.09 | ||
| KALV | kalvista pharmaceuticals inc | 2.82 | 4,941,800 | 55,867,000 | unchanged | 0.00 | ||
| PTCT | ptc therapeutics inc | 2.72 | 1,100,000 | 53,724,000 | added | 10.00 | ||
| AGLE | spyre therapeutics inc | 2.42 | 3,200,000 | 47,904,000 | added | 56.1 | ||
| EOLS | evolus inc | 2.33 | 4,997,400 | 46,026,000 | unchanged | 0.00 | ||
| VRDN | viridian therapeutics inc | 2.01 | 2,842,920 | 39,744,100 | added | 1.79 | ||
| ITOS | iteos therapeutics inc | 1.93 | 3,826,690 | 38,152,100 | added | 42.3 | ||
| CMPX | compass therapeutics inc | 1.77 | 13,496,200 | 35,090,100 | added | 22.11 | ||
| ACAD | acadia pharmaceuticals inc | 1.64 | 1,500,000 | 32,355,000 | unchanged | 0.00 | ||
| VERA | vera therapeutics inc cl a | 1.61 | 1,350,000 | 31,806,000 | added | 800 | ||
| MRUS | merus n v | 1.59 | 600,000 | 31,560,000 | added | 500 | ||
| REPL | replimune group inc | 1.50 | 3,200,000 | 29,728,000 | added | 10.34 | ||
| ANAB | anaptysbio inc | 1.49 | 1,330,880 | 29,545,500 | reduced | -13.87 | ||
| legend biotech corp | 1.49 | 830,000 | 29,456,700 | unchanged | 0.00 | |||
| biontech se | 1.45 | 270,000 | 28,746,900 | unchanged | 0.00 | |||
